Cargando…
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas
Pulmonary sarcomatoid carcinomas (PSC) are a rare group of lung cancer with a median overall survival of 9–12 months. PSC are divided into five histotypes, challenging to diagnose and treat. The identification of PSC biomarkers is warranted, but PSC molecular profile remains to be defined. Herein, a...
Autores principales: | Alì, Greta, Bruno, Rossella, Poma, Anello Marcello, Affinito, Ornella, Monticelli, Antonella, Piaggi, Paolo, Ricciardi, Sara, Lucchi, Marco, Melfi, Franca, Chella, Antonio, Cocozza, Sergio, Fontanini, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401130/ https://www.ncbi.nlm.nih.gov/pubmed/30837581 http://dx.doi.org/10.1038/s41598-019-40016-8 |
Ejemplares similares
-
Gene Expression Analysis of Biphasic Pleural Mesothelioma: New Potential Diagnostic and Prognostic Markers
por: Bruno, Rossella, et al.
Publicado: (2022) -
Prevalence of Delta-Like Protein 3 in a Consecutive Series of Surgically Resected Lung Neuroendocrine Neoplasms
por: Alì, Greta, et al.
Publicado: (2021) -
New Immunohistochemical Markers for Pleural Mesothelioma Subtyping
por: Di Stefano, Iosè, et al.
Publicado: (2023) -
Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer
por: Alì, Greta, et al.
Publicado: (2023) -
Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis
por: Bruno, Rossella, et al.
Publicado: (2016)